A Fast One‐Step Extraction and UPLC–MS/MS Analysis for E2/D2 Series Prostaglandins and Isoprostanes

Lipids - 2013
Stephen A. Brose1, Andrew G. Baker2, Mikhail Y. Golovko1
1Department of Pharmacology, Physiology, and Therapeutics, School of Medicine and Health Sciences, University of North Dakota, 501 N. Columbia Rd., Grand Forks, ND, 58202-9037 USA
2Waters Corporation, Milford, MA, 01757 USA

Tóm tắt

Abstract

Prostaglandins (PG) and isoprostanes (iso‐PG) may be derived through cyclooxygenase or free radical pathways and are important signaling molecules that are also robust biomarkers of oxidative stress. Their quantification is important for understanding many biological processes where PG, iso‐PG, or oxidative stress are involved. One of the common methods for PG and iso‐PG quantifications is LC–MS/MS that allows a highly selective, sensitive, simultaneous analysis for prostanoids without derivatization. However, the currently used LC–MS/MS methods require a multi‐step extraction and a long (within an hour) LC separation to achieve simultaneous separation and analysis of the major iso‐PG. The developed and validated for brain tissue analysis one‐step extraction protocol and UPLC–MS/MS method significantly increases the recovery of the PG extraction up to 95 %, and allows for a much faster (within 4 min) major iso‐PGE2 and ‐PGD2 separation with 5 times narrower chromatographic peaks as compared to previously used methods. In addition, it decreases the time and cost of analysis due to the one‐step extraction approach performed in disposable centrifuge tubes. All together, this significantly increases the sensitivity, and the time and cost efficiency of the PG and iso‐PG analysis.

Từ khóa


Tài liệu tham khảo

10.1016/j.prostaglandins.2005.07.001

10.1016/j.brainresrev.2006.02.002

10.1016/S0090-6980(02)00031-X

10.1016/S0074-7742(07)82014-9

10.1038/nature09613

10.1152/ajpregu.90430.2008

10.1523/JNEUROSCI.3204-06.2007

10.1111/j.1471-4159.1982.tb10847.x

10.1073/pnas.82.20.7071

10.1007/BF02858504

10.1159/000086629

10.1016/j.pharmthera.2004.06.003

10.1016/j.brainresrev.2004.12.024

10.1007/s00281-003-0132-4

10.1046/j.1471-4159.2003.02246.x

10.1016/j.chemphyslip.2003.09.011

10.1074/jbc.M303984200

10.1073/pnas.87.23.9383

10.1016/S0021-9258(17)41781-9

10.1073/pnas.89.22.10721

10.2174/138161206776055985

10.1006/abbi.1998.0645

10.1016/S0022-2275(20)32187-8

10.1016/0090-6980(94)90011-6

Milne GL, 2007, Methods in enzymology, 113

10.1194/jlr.R800037-JLR200

10.1016/S0021-9258(17)41781-9

10.1074/jbc.M507340200

10.2174/1381612053507521

10.2174/1568010054022051

10.1007/s00109-001-0289-z

10.1016/j.ijdevneu.2004.07.002

10.1194/jlr.D700030-JLR200

10.1016/j.ab.2005.12.003

10.1002/rcm.2697

10.1194/jlr.D013441

10.1016/j.ab.2007.08.041

10.1074/jbc.M107471200

10.1016/j.jchromb.2005.09.001

10.1016/j.plefa.2006.07.015

10.1006/abio.2001.5325

10.1194/jlr.D023739

10.1016/j.prostaglandins.2012.07.002

10.1002/rcm.4926

10.1016/0003-2697(84)90559-1

10.1002/rcm.1170

Stenson WF, 1999, Current protocols in immunology, 7.33.31

10.1016/0003-2697(87)90375-7

10.1054/plef.2002.0381

10.1194/jlr.M800200-JLR200

10.1016/j.neulet.2007.12.031

10.1007/s11010-008-0008-y

10.1002/rcm.6367

10.1139/y59-099

10.1016/S1044-0305(02)00420-8

10.1073/pnas.87.23.9383

10.1016/j.chemphyslip.2003.09.011

10.1073/pnas.89.22.10721

10.1016/j.ab.2012.10.022

10.1371/journal.pone.0030378

Powell WS, 1999, Eicosanoid protocols, 11, 10.1385/1-59259-263-5:11

10.1007/s11064-011-0439-9

10.1016/0003-2697(90)90623-H